Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Braz. J. Anesth. (Impr.) ; 73(2): 177-185, March-Apr. 2023. graf
Artículo en Inglés | LILACS | ID: biblio-1439592

RESUMEN

Abstract Background The precise underlying mechanism of antioxidant effects of dexmedetomidine-induced neuroprotection against cerebral ischemia has not yet been fully elucidated. Activation of Nuclear factor erythroid 2-related factor (Nrf2) and Heme Oxygenase-1 (HO-1) represents a major antioxidant-defense mechanism. Therefore, we determined whether dexmedetomidine increases Nrf2/HO-1 expression after global transient cerebral ischemia and assessed the involvement of Protein Kinase C (PKC) in the dexmedetomidine-related antioxidant mechanism. Methods Thirty-eight rats were randomly assigned to five groups: sham (n = 6), ischemic (n = 8), chelerythrine (a PKC inhibitor; 5 mg.kg-1 IV administered 30 min before cerebral ischemia) (n = 8), dexmedetomidine (100 µg.kg-1 IP administered 30 min before cerebral ischemia (n = 8), and dexmedetomidine + chelerythrine (n = 8). Global transient cerebral ischemia (10 min) was applied in all groups, except the sham group; histopathologic changes and levels of nuclear Nrf2 and cytoplasmic HO-1 were examined 24 hours after ischemia insult. Results We found fewer necrotic and apoptotic cells in the dexmedetomidine group relative to the ischemic group (p< 0.01) and significantly higher Nrf2 and HO-1 levels in the dexmedetomidine group than in the ischemic group (p< 0.01). Additionally, chelerythrine co-administration with dexmedetomidine attenuated the dexmedetomidine-induced increases in Nrf2 and HO-1 levels (p< 0.05 and p< 0.01, respectively) and diminished its beneficial neuroprotective effects. Conclusion Preischemic dexmedetomidine administration elicited neuroprotection against global transient cerebral ischemia in rats by increasing Nrf2/HO-1 expression partly via PKC signaling, suggesting that this is the antioxidant mechanism underlying dexmedetomidine-mediated neuroprotection.


Asunto(s)
Animales , Ratas , Daño por Reperfusión/prevención & control , Isquemia Encefálica , Proteína Quinasa C/metabolismo , Proteína Quinasa C/farmacología , Ataque Isquémico Transitorio , Estrés Oxidativo , Fármacos Neuroprotectores/farmacología , Dexmedetomidina/farmacología , Hemo-Oxigenasa 1/metabolismo , Hemo-Oxigenasa 1/farmacología , Factor 2 Relacionado con NF-E2/metabolismo , Factor 2 Relacionado con NF-E2/farmacología , Hemo Oxigenasa (Desciclizante)/farmacología , Antioxidantes/metabolismo , Antioxidantes/farmacología
2.
The Journal of Korean Academy of Prosthodontics ; : 244-249, 1997.
Artículo en Coreano | WPRIM | ID: wpr-112777

RESUMEN

Proper hygienic care of removable dentures is an important means of maintaining a healthy oral mucosa on denture wearers. Denture cleansing is often poor due to improper mechanical and the inefficient chemical cleansing of dentures. Dentists and patients should realize that microbial plaque on dentures may be harmful to both the oral mucosa and the patient's general health. This literature review was aimed to evaluate materials and methods for cleansing dentures and to discuss different means of keeping dentures plaque-free. A routine denture cleansing regimen should be designed to remove and prevent reaccumulation of microbial plaque and also to remove mucin, food debris, calculus, and exogenous discoloration. The combined use of chemical and mechanical cleansing is highly recommended for patients to clean their denture effciently.


Asunto(s)
Humanos , Cálculos , Alisadura de la Restauración Dental , Odontólogos , Limpiadores de Dentadura , Dentaduras , Mucosa Bucal , Mucinas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA